Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript

PresentationI would now like to hand the conference over to your speaker today, Amy Burroughs, Chief Executive Officer. Please go ahead. Thank you so much, operator.Good day, and thank you for standing by. Welcome to the Terns Pharmaceuticals TERN-701 December 2025 Data Update Conference Call. Please be advised that today's conference is being recorded.Amy BurroughsCEO & Director Thank you so much, operator. Good afternoon, everyone. I'm Amy Burroughs, Chief Executive Officer of Terns Pharmaceuticals. On be ...